Skip to content

Posted byTeam TCX

When it comes to Value Analysis, too many medtech teams get lost in the trees. They highlight individual product features, a single clinical outcome, or one stakeholder’s perspective. But Value Analysis Committees (VACs) want more than isolated wins. They want to understand how a product affects the full care pathway and the people who deliver care every day.

Why the big picture matters

  • A solution that looks strong clinically can still face resistance if it disrupts workflows, reimbursement processes, or daily operations.
  • Hospitals and IDNs consider length of stay, readmissions, staffing efficiency, and quality metrics alongside clinical outcomes.
  • Focusing only on features risks missing what matters most: usability, accessibility, and alignment with organizational goals.

Seeing the full picture means recognizing that adoption is rarely decided on clinical impact alone. A strong business case must account for how your product integrates into daily operations, contributes to financial goals, and supports the broader mission of improving patient outcomes. Medtech companies that miss this perspective risk being seen as point solutions rather than strategic partners.

What “seeing the whole forest” looks like

  • Engaging frontline teams: Nursing practice committees, department leaders, and staff using the product often spot roadblocks that data alone will not reveal.
  • Identifying pain points: Listening sessions and open dialogue uncover hidden obstacles such as supply accessibility or product usability that can derail adoption.
  • Evaluating usability early: Human factors engineering ensures products work in real-world conditions, not just on paper. It is about more than “great” feedback; it is about consistent, reliable use across different staff and settings.
  • Bridging silos through collaboration: Vendor fairs and facilitated discussions give providers, staff, and suppliers the space to ask questions, test products, and surface honest feedback.

This approach is not just about proving the value of your product but about reducing friction across the system. By listening closely, validating usability, and connecting insights across departments, you demonstrate that your solution is more than a device. It becomes part of a larger strategy to drive efficiency, safety, and better outcomes.

How TCX helps

At TCX, we help medtech teams connect the dots between clinical outcomes, operational realities, and financial imperatives. By combining frontline insights with strategic alignment, we make sure your value story resonates with decision makers and withstands committee scrutiny. When you walk into a Value Analysis Committee, your case is already framed around what matters to the organization as a whole.

This is where our role as a Clinical Concierge Organization is most valuable. We partner with medtech companies to uncover the barriers, align messaging with the CFO framework, and translate clinical promise into organizational impact. The result is a value story that feels complete, credible, and ready for action.

📺 Ready to strengthen your Value Analysis strategy? Watch our full webinar for expert insights, then download the Value Analysis CFO Workbook to start building a business case that decision makers cannot ignore.

Ready to Advance Your Value Analysis Initiatives?

Complete the form below, and a Value Analysis Expert will connect with you to discuss your projects or answer any questions you have.